临床试验/EUCTR2020-001431-27-DE

EUCTR2020-001431-27-DE进行中（未招募）1 期

Treatment of Sars-CoV2 infections (Covid-19) in patients without or with chronic kidney disease (CKD) with valsartan vs placebo, a three-armed randomized, partly blinded trial

Klinikum St. Georg gGmbH0 个研究点目标入组 300 人开始时间: 2020年4月7日最近更新: 2021年6月21日

适应症

相关药物

试验速览

阶段: 1 期
状态: 进行中（未招募）
发起方: Klinikum St. Georg gGmbH
入组人数: 300

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional clinical trial of medicinal product

入排标准

性别: All

入选标准

•- Patients aged over 18 years with given consent, first positive Sars-Cov2 detection within the last three days
•- Patients with pre-existing chronic renal insufficiency in any degree of severity
•- Patients of both gender
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 200
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 100

排除标准

•- intolerance to RAS-I and ARB
•- Contraindications against ACE/ARB according to current clinical standard
•- History of falls (more than 2 falls in the last 8 weeks)
•- Symptomatic hypotension (i.e. blood pressure < 100 mmHg systolic and/or 50 mmHg diastolic together with hypotensive symptoms)
•- Acute renal failure from stage 2
•- pregnancy

研究者

发起方

Klinikum St. Georg gGmbH

相似试验

Treatment of Sars-CoV2 infections (Covid-19) with valsartan vs placebo, a three-armed randomized, partly blinded trialCovid-19

DRKS00021732Klinikum St. Georg gGmbH300

se of Hemopurifier Device For The Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans.

CTRI/2021/10/037591Aethlon Medical Inc

Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumabsevere SARS-CoV-2 pneumoniaCOVID-19SARS-CoV-2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusSevere Acute Respiratory Syndrome

RPCEC00000311Center of Molecular Immunology (CIM)80

Cancelled by the investigator Diagnosis and treatment of novel coronavirus pneumonia (COVID-19) in common and severe cases based on the theory of ''Shi-Du-Yi (damp and plague)''ovel Coronavirus Pneumonia (COVID-19)

ITMCTR2000003128The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine

Will treatment with a drug named colchicine be useful in treating Corona virus infection in kidney failure patients who are on regular dialysis?

CTRI/2021/05/033537CMC Fluid research Funding